346 related articles for article (PubMed ID: 10095798)
1. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
Brandi L; Nielsen PK; Bro S; Daugaard H; Olgaard K
J Intern Med; 1998 Aug; 244(2):121-31. PubMed ID: 10095798
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
Weinreich T; Ritz E; Passlick-Deetjen J
Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia during pulse vitamin D3 therapy in CAPD patients treated with low calcium dialysate: the role of the decreasing serum parathyroid hormone level.
Chagnac A; Ori Y; Weinstein T; Zevin D; Korzets A; Hirsh J; Edelstein S; Gafter U
J Am Soc Nephrol; 1997 Oct; 8(10):1579-86. PubMed ID: 9335387
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2.
Mornière P; Maurouard C; Boudailliez B; Westeel PF; Achard JM; Boitte F; el Esper N; Compagnon M; Maurel G; Bouillon R
Nephron; 1992; 60(2):154-63. PubMed ID: 1552999
[TBL] [Abstract][Full Text] [Related]
7. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients.
Johnson DW; Rigby RJ; McIntyre HD; Brown A; Freeman J
Nephrol Dial Transplant; 1996 Jan; 11(1):88-93. PubMed ID: 8649658
[TBL] [Abstract][Full Text] [Related]
9. Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders.
Parsons V; Baldwin D; Moniz C; Marsden J; Ball E; Rifkin I
Nephron; 1993; 63(4):379-83. PubMed ID: 8459870
[TBL] [Abstract][Full Text] [Related]
10. Low- and high-turnover bone disease in continuous ambulatory peritoneal dialysis: effects of low-Ca2+ peritoneal dialysis solution.
Carozzi S; Nasini MG; Santoni O; Pietrucci A
Perit Dial Int; 1993; 13 Suppl 2():S473-5. PubMed ID: 8399644
[TBL] [Abstract][Full Text] [Related]
11. Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium.
Moriniere P; el Esper N; Viron B; Judith D; Bourgeon B; Farquet C; Gheerbrant J; Chapuy M; Van Orshoven A; Pamphile R
Kidney Int Suppl; 1993 Jun; 41():S121-4. PubMed ID: 8320904
[TBL] [Abstract][Full Text] [Related]
12. Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis--result of a nationwide survey in Japan.
Yamamoto H; Kasai K; Hamada C; Hasegawa H; Higuchi C; Hiramatsu M; Hosoya T; Itami N; Kawanishi H; Kubota M; Masakane I; Minakuchi J; Mitarai T; Nakao T; Suzuki H; Tomo T; Kawaguchi Y;
Perit Dial Int; 2008 Jun; 28 Suppl 3():S128-30. PubMed ID: 18552242
[TBL] [Abstract][Full Text] [Related]
13. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
Weinreich T; Passlick-Deetjen J; Ritz E
Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
[TBL] [Abstract][Full Text] [Related]
14. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
15. [Long-term treatment with large doses of alphacalicidol in secondary hyperparathyroidism of patients dialyzed for end stage renal failure].
Matuszkiewicz-Rowińska J; Niemczyk S; Pacocha E; Puka J; Switalski M; Bogdańska-Straszyńska B; Ostrowski K
Pol Arch Med Wewn; 1996 Jul; 96(1):15-22. PubMed ID: 8966141
[TBL] [Abstract][Full Text] [Related]
16. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
Honkanen E; Kala AR; Grönhagen-Riska C; Ikäheimo R
Adv Perit Dial; 1992; 8():356-61. PubMed ID: 1361822
[TBL] [Abstract][Full Text] [Related]
17. Does low-calcium dialysate accelerate secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients?
Rotellar C; Kinsel V; Goggins M; Tarman G; Stull M; Mazzoni MJ; Mosher WF; Rakowski TA; Winchester JF
Perit Dial Int; 1993; 13 Suppl 2():S471-2. PubMed ID: 8399643
[TBL] [Abstract][Full Text] [Related]
18. Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patients.
Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Pietrucci A
ASAIO J; 1992; 38(3):M593-5. PubMed ID: 1457929
[TBL] [Abstract][Full Text] [Related]
19. Calcium concentration in the CAPD dialysate: what is optimal and is there a need to individualize?
Bro S; Brandi L; Daugaard H; Olgaard K
Perit Dial Int; 1997; 17(6):554-9. PubMed ID: 9655154
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients.
Pagliari B; Baretta A; De Cristofaro V; Samà F; Cantaluppi A; Martis L; Imbasciati E
Perit Dial Int; 1991; 11(4):326-9. PubMed ID: 1751598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
